-
HC Wainwright Reiterates "Buy" Rating for Cytokinetics (NASDAQ:CYTK)
Source: Buzz FX / 20 Dec 2024 09:56:14 America/Chicago
HC Wainwright Reiterates "Buy" Rating for Cytokinetics (NASDAQ:CYTK) Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Cytokinetics ( NASDAQ:CYTK - Get Free Report ) 's stock had its "buy" rating reaffirmed by analysts
Read more...